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Abstract 
Objective; To determine the frequency of renal dysfunction in patients with acute coronary syndrome at a 
tertiary care hospital. Study design; Descriptive Cross-sectional study. Setting; Department of Medicine, 
Nishtar Hospital Multan. Material and Methods; Consecutive 285 patients who met inclusion criteria of our 
study were enrolled from department of Cardiology, Nishtar Hospital Multan. History was taken and relevant 
investigations were done. Computer based formula for MDRD eGFR was used to calculate eGFR in our patients. 
All these findings were entered in pre-designed, pre – tested study questionnaire. Data was entered and analyzed 
using computer based software SPSS version 20. All the quantitative variables of the study (such as age, serum 
creatinine level, GFR value) were calculated for mean and standard deviation. Frequencies and percentages were 
calculated for categorical variables like gender, residential area, socioeconomic status, level of education, H/O 
diabetes, H/O hypertension, H/O smoking and family history of IHD  etc. Results; We studied 285 patients of 
acute coronary syndrome admitted in Cardiology department of Nishtar Hospital Multan, 210 (73.7%) were male 
and 75 (26.3%) female. One hundred eighty (63.2%) were from rural area and 105 (36.8%) were urban. One 
hundred thirty two (46.3%) were from low income group, 144 (50.5%) from middle income and 9 (3.2%) were 
from high income group. Two hundred four (71.6%) patients presented with chest pain and 72 (25.3%) presented 
with chest pain and shortness of breath. One hundred eight (37.9%) were hypertensive, 63 (32.6%) were 
diabetic, 135 (47.4%) were smokers and family history of IHD was present in 102 (35.8%) of the cases. eGFR 
was calculated by MDRD eGFR formula. eGFR was less than 30 ml/min/1.73 m
2 
in 30 (10.5%) of the cases, 31-
60 ml/min/1.73 m2 in 66 (23.2%) cases and eGFR was more than 60 ml/min/1.73 m2 in 189 (66.3%) of the cases.  
Conclusion; The present study reveals that the substantial proportion of our study patients have underlying renal 
dysfunction. So eGFR estimation in ACS patients should be given due consideration. This will help in the 
management of these patients and may improve short and long term disease outcome. Further follow up studies 
especially in terms of morbidity and mortality in this sub-group of patients are suggested.  
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Introduction 
Among the cardiac emergencies, ACS still remains the major catastrophic cardiac emergency  and leading cause 
of morbidity and mortality in developing countries 
1-3
.  In hospital mortality has been reported to be 13.5% 
among the admitted ST segment elevation MI (STEMI) patients 
4
. The patients of ACS are at high risk of short 
and long term adverse out comes. The ACS is highest cause of death in UK. The  poor prognostic factors include 
advancing age, presence and severity of ECG changes, high level of bio markers of myocardial infarction 
especially serum Troponin levels, presence of left ventricular dysfunction, cardiogenic shock, heart failure, heart 
rate and arrhythmias, renal impairment, diabetes mellitus, hypertension and anemia 
5-8
.  
Renal dysfunction  is an independent and important risk factor for cardiac diseases and is also a strong predictor 
of adverse outcomes in patients with various cardiovascular conditions including ACS, even if it is mild 9-15. The 
adverse out come in MI patients associated with renal dysfunction has been reported by Anavekar et al 
13
.
  
Glomerular   Filtration Rate (GFR) estimation is an important and independent  predictor of in hospital and 
outpatient mortality in patients with ACS 
16
. In Valsartan acute MI trial (VALIANT), 14527 patients of MI were 
studied and  it has been highlighted in this study that even mild renal dysfunction, assessed on the basis of 
estimated GFR, is to be considered as major risk factor for cardiovascular complications in patients of MI 
13
. It 
was further noted that 10 units reduction of GFR was associated with 10% increased risk of adverse outcomes in 
these patients. Amount of renal dysfunction as assessed by serum creatinine may be misleading because 
insignificant slight increase in serum creatinine, or even patients with normal creatinine may have significant 
renal dysfunction as estimated by Modification of Diet in Renal Diseases (MDRD eGFR) formula. It was also 
found that up to 30 % of these patients undergoing primary percutaneous coronary intervention are expected to 
have significant renal dysfunction as defined by MDRD eGFR less than 60 ml/min/1.73 m
2
. 
17
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Hence renal dysfunction remains important issue in patients with ACS. The present study has been conducted to 
see the frequency of renal dysfunction on the basis of MDRD eGFR in ACS patients.  
 
Material and methods; 
Study design; Descriptive cross – sectional study. 
Setting; Department of Medicine, Nishtar Hospital Multan. 
Sample size; 285 patients with ACS. 
Sampling Technique; Non – probability, purposive sampling. 
Inclusion Criteria; 
1. Both genders. 
2. Age range (More than 20 years). 
3. Patients with ACS. 
Exclusion Criteria; 
1. Patients having any malignancy will not be included. 
2. Renal transplanted patients. 
3. Pregnant ladies. 
4. Patients who have already undergone cardiac intervention or surgery. 
5. Who do not give consent for participation. 
Consecutive 285 patients who met inclusion criteria of our study were enrolled from department of 
Cardiology, Nishtar Hospital Multan. Informed written consent was taken from each patient describing them 
objectives and benefits of this study, ensuring them confidentiality of the information provided and the fact that 
there is no risk involved to the patient while taking part in this study.  
Relevant history was taken. Clinical examination and relevant investigations were carried out. All socio-
demographic information (like age, gender, residential status, socioeconomic status, etc) was also asked. 
Computer based formula for MDRD eGFR was used to calculate eGFR in our patients. All these findings were 
entered in pre-designed, pre – tested study questionnaire. 
Data was entered and analyzed using computer based software SPSS version 20. All the quantitative 
variables of the study (such as age, serum creatinine level, GFR value) were calculated for mean and standard 
deviation. Frequencies and percentages were calculated for categorical variables like gender, residential area, 
socioeconomic status, level of education, H/O diabetes, H/O hypertension, H/O smoking and family history of 
IHD  etc. 
 
Results; 
We studied 285 patients of acute coronary syndrome admitted in Cardiology department of Nishtar Hospital 
Multan, out of which 210 (73.7%) were male and 75 (26.3%) female. One hundred eighty (63.2%) were from 
rural area and 105 (36.8%) were urban. One hundred thirty two (46.3%) were from low income group, 144 
(50.5%) from middle income and 9 (3.2%) were from high income group. Two hundred four (71.6%) patients 
presented with chest pain and 72 (25.3%) presented with chest pain and shortness of breath. One hundred eight 
(37.9%) were hypertensive, 63 (32.6%) were diabetic, 135 (47.4%) were smokers and family history of IHD was 
present in 102 (35.8%) of the cases. eGFR was calculated by MDRD eGFR formula. eGFR was less than 30 
ml/min/1.73 m
2 
in 30 (10.5%) of the cases and eGFR was 31-60 ml/min/1.73 m
2 
in 66 (23.2%) cases and eGFR 
was more than 60 ml/min/1.73 m
2 
in 189 (66.3%) of the cases.  
 
Discussion;         
Both ACS and renal dysfunction patients have cardiovascular risk factors in common and various researchers 
have studied the existence of  renal dysfunction in ACS patients. The underlying uremic risk factors for 
accelerated atherogenesis in renal dysfunction patients, put these patients to further risk for coronary artery 
disease. Renal insufficiency has been described as an independent risk factor for cardiac diseases. The 
independent association between renal dysfunction underlying in ACS patients has also been studied 
18, 19
. Renal 
dysfunction is also an important predictor of poor short as well as long term outcomes in ACS patients 
13
.  
Indeed, renal insufficiency in ACS patients doubles the mortality rates and it is 3rd important cause for prediction 
of mortality in these patients 
20
.  
 
We studied 285 admitted patients of ACS. Two hundred ten (73.7%) were male and 75 (23.3%) were female, 
eGFR was calculated. In our study eGFR was less than 30 ml/min/1.73m2 in 30 (10.5%) of cases, 31 – 60 
ml/min/1.73m
2
 in 66 (23.2%) of cases and it was more than 60 ml/min/1.73m
2 
in rest of cases.  Among the ACS 
patients, 48 (16.8 %) with low eGFR (i.e. 60 ml/min/1.73m
 2
) were diabetic, 42 (14.7%) were hypertensive, 45 
(15.8 %) were smokers and 45 (15.8%) were having positive family history of IHD.  
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It has also been reported that almost 40 % of the cases with non ST segment elevation myocardial infarction 
(MI) and 30 % of the cases having ST segment elevation MI have renal insufficiency as defined by eGFR less 
than 60 ml/min/1.73 m2 .21The pathophysiology in ACS patients with underlying renal dysfunction has been 
studied 
22
 Lesions in the coronaries of patients with renal dysfunction were found to be longer with more luminal 
encroachment and have higher plaque burden compared to coronaries of non renal dysfunction patients. 
Coronary plaque composition assessed with radio frequency IVUS depicted greater necrotic core with dense 
calcium and less fibrous tissue, all these changes make the coronary plaque less stable. Furthermore serum 
matrix metalloproteinases were found raised in cases of moderate to severe renal dysfunction patients and these 
result in progression of plaque and  degradation of overlying fibrous cap 
23
.  Experimental data support the view 
that renal dysfunction increases foam cell generation by stimulating macrophage entry into vascular endothelium 
24. Further studies have revealed an accelerated infarct expansion, active inflammation and oxidative stress in 
patients having ACS with renal dysfunction 25. Morenzi et al 20 have suggested that eGFR should be done as 
baseline and should be part of evaluation of any patient admitted with ACS, especially if they have hypertension, 
diabetes mellitus and low hemoglobin. Similar findings have also been suggested by Hemmelgarn et al 
26 .  
Amsterdam et al 27 suggested that non-ST segment elevation MI patients must have eGFR estimated initially and 
throughout the optimal care of these patients, this will decrease complications and hence mortality. 
 
The baseline estimation, while these ACS patients are being optimally treated, may prevent complications like 
contrast induced nephropathy, coronary stent thrombosis and re-stenosis, bleeding can be minimized while doing 
reperfusion procedures. ACS patients with underlying renal dysfunction have prolongation of bleeding time, 
abnormal platelet aggregation and adhesion and also have state of hyper-coagulation 
28-29
. Hence anti-thrombic 
therapy, use of heparin, anti-platelet aggregation agents and drugs like statins may be modified in renal 
dysfunction patients.  
 
Conclusion;  
The present study reveals that the substantial proportion of our study patients have underlying renal dysfunction. 
So eGFR estimation in ACS patients should be given due consideration. This will help in the management of 
these patients and may improve short and long term disease outcome. Further follow up studies especially in 
terms of morbidity and mortality in this sub-group of patients are suggested.  
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